

Neurovascular Embolization Device Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
The Neurovascular Embolization Device market is experiencing robust growth, driven by increasing incidences of neurovascular diseases and advancements in technology. The market is projected to reach approximately $2.5 billion by 2027, with a notable CAGR due to rising demand for minimally invasive procedures and effective treatment options. Competitive dynamics are intensifying.
Request Sample Report
◍ Medtronic
◍ Stryker
◍ Terumo
◍ Johnson & Johnson Services
◍ Penumbra
◍ Balt Extrusion
◍ B. Braun Melsungen
◍ Integra LifeSciences
◍ Resonetics
◍ Acandis
The Neurovascular Embolization Device Market features key players like Medtronic, Stryker, Terumo, and Johnson & Johnson, focusing on innovative products, research, and strategic partnerships to enhance market growth. Companies support the market with advancements in technology, driving sales through improved outcomes and expanding applications in neurovascular interventions. Revenue figures include:
- Medtronic: $30 billion (2023)
- Stryker: $18 billion (2023)
- Terumo: $6 billion (2023)
Request Sample Report
◍ Aneurysm Clips ◍ Hospital ◍ School Of Medicine
◍ Embolization Coils
◍ Flow Diversion Stents
◍ Other Request Sample Report
◍ Liquid Embolic Systems
Request Sample Report
$ X Billion USD